Surfactant protein B-derived peptides as endosomal escape enhancers for pulmonary delivery of siRNA
- Author
- Lore Herman (UGent) , Roberta Guagliardo, Agata Zamborlin (UGent) , Qiaoyu Liu (UGent) , Jesús Pérez-Gil, Stefaan De Smedt (UGent) and Koen Raemdonck (UGent)
- Organization
- Project
-
- REpurposing lung Surfactant Protein B for Inhalation therapy with RNA therapeutics
- Repurposing lung surfactant protein B for inhalation therapy with RNA therapeutics
- Novel molecular intervention technology for infectious and allergic respiratory diseases
- RNA-MAGIC: RNA-based bioMArkers and tarGets In asthma and Chronic Obstructive Pulmonary Disease (COPD)
- Abstract
- Respiratory diseases still cause significant mortality and morbidity worldwide, highlighting the need for new inhalable drugs. RNA therapeutics, which have the potential to modulate the expression of virtually any gene, could address this unmet medical need. Nevertheless, clinical translation requires the design of RNA formulations able to overcome the extra- and intracellular barriers in the lung. We previously discovered that the endogenous cationic amphiphilic surfactant protein B (SP-B) promotes cytosolic delivery of small interfering RNA (siRNA) in lung-related cell types via endosomal membrane fusion. However, to bypass drawbacks related to the use of animal-derived SP-B, there is a keen interest in developing synthetic SP-B analogues with comparable activity. Here, we show that native SP-B can successfully be replaced by smaller peptides, with the N-terminal heptapeptide and amphipathic helix being minimally required to promote siRNA-induced gene silencing. Peptidolipidcoated nanogels were designed and demonstrated equivalent siRNA delivery efficacy compared to state-of-the-art lipid nanoparticles (LNPs). Moreover, they exhibit enhanced resistance to vibrating mesh nebulization and reduced inflammatory activation of bronchial epithelial cells. Collectively, the discovery of SP-B peptides as RNA delivery enhancers holds promise for developing potent inhalable RNA formulations with favorable safety profiles, of value for the treatment of chronic inflammatory pathologies.
- Keywords
- Nanomedicine, Pulmonary delivery, Inhalation, Pulmonary surfactant, Small interfering RNA, Bio-inspired nanoparticles, N-TERMINAL SEGMENT, MESSENGER-RNA, SP-C, SYNTHETIC SURFACTANT, LIPID NANOPARTICLES, COATED NANOGELS, EFFICIENT, SP-B1-25, ALANINE, INHIBITION
Downloads
-
Surfactant.pdf
- full text (Accepted manuscript)
- |
- open access
- |
- |
- 2.26 MB
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 14.51 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01JQ46KB2680PC1CK81REBC8SA
- MLA
- Herman, Lore, et al. “Surfactant Protein B-Derived Peptides as Endosomal Escape Enhancers for Pulmonary Delivery of SiRNA.” JOURNAL OF CONTROLLED RELEASE, vol. 381, 2025, doi:10.1016/j.jconrel.2025.02.067.
- APA
- Herman, L., Guagliardo, R., Zamborlin, A., Liu, Q., Pérez-Gil, J., De Smedt, S., & Raemdonck, K. (2025). Surfactant protein B-derived peptides as endosomal escape enhancers for pulmonary delivery of siRNA. JOURNAL OF CONTROLLED RELEASE, 381. https://doi.org/10.1016/j.jconrel.2025.02.067
- Chicago author-date
- Herman, Lore, Roberta Guagliardo, Agata Zamborlin, Qiaoyu Liu, Jesús Pérez-Gil, Stefaan De Smedt, and Koen Raemdonck. 2025. “Surfactant Protein B-Derived Peptides as Endosomal Escape Enhancers for Pulmonary Delivery of SiRNA.” JOURNAL OF CONTROLLED RELEASE 381. https://doi.org/10.1016/j.jconrel.2025.02.067.
- Chicago author-date (all authors)
- Herman, Lore, Roberta Guagliardo, Agata Zamborlin, Qiaoyu Liu, Jesús Pérez-Gil, Stefaan De Smedt, and Koen Raemdonck. 2025. “Surfactant Protein B-Derived Peptides as Endosomal Escape Enhancers for Pulmonary Delivery of SiRNA.” JOURNAL OF CONTROLLED RELEASE 381. doi:10.1016/j.jconrel.2025.02.067.
- Vancouver
- 1.Herman L, Guagliardo R, Zamborlin A, Liu Q, Pérez-Gil J, De Smedt S, et al. Surfactant protein B-derived peptides as endosomal escape enhancers for pulmonary delivery of siRNA. JOURNAL OF CONTROLLED RELEASE. 2025;381.
- IEEE
- [1]L. Herman et al., “Surfactant protein B-derived peptides as endosomal escape enhancers for pulmonary delivery of siRNA,” JOURNAL OF CONTROLLED RELEASE, vol. 381, 2025.
@article{01JQ46KB2680PC1CK81REBC8SA,
abstract = {{Respiratory diseases still cause significant mortality and morbidity worldwide, highlighting the need for new inhalable drugs. RNA therapeutics, which have the potential to modulate the expression of virtually any gene, could address this unmet medical need. Nevertheless, clinical translation requires the design of RNA formulations able to overcome the extra- and intracellular barriers in the lung. We previously discovered that the endogenous cationic amphiphilic surfactant protein B (SP-B) promotes cytosolic delivery of small interfering RNA (siRNA) in lung-related cell types via endosomal membrane fusion. However, to bypass drawbacks related to the use of animal-derived SP-B, there is a keen interest in developing synthetic SP-B analogues with comparable activity. Here, we show that native SP-B can successfully be replaced by smaller peptides, with the N-terminal heptapeptide and amphipathic helix being minimally required to promote siRNA-induced gene silencing. Peptidolipidcoated nanogels were designed and demonstrated equivalent siRNA delivery efficacy compared to state-of-the-art lipid nanoparticles (LNPs). Moreover, they exhibit enhanced resistance to vibrating mesh nebulization and reduced inflammatory activation of bronchial epithelial cells. Collectively, the discovery of SP-B peptides as RNA delivery enhancers holds promise for developing potent inhalable RNA formulations with favorable safety profiles, of value for the treatment of chronic inflammatory pathologies.}},
articleno = {{113571}},
author = {{Herman, Lore and Guagliardo, Roberta and Zamborlin, Agata and Liu, Qiaoyu and Pérez-Gil, Jesús and De Smedt, Stefaan and Raemdonck, Koen}},
issn = {{0168-3659}},
journal = {{JOURNAL OF CONTROLLED RELEASE}},
keywords = {{Nanomedicine,Pulmonary delivery,Inhalation,Pulmonary surfactant,Small interfering RNA,Bio-inspired nanoparticles,N-TERMINAL SEGMENT,MESSENGER-RNA,SP-C,SYNTHETIC SURFACTANT,LIPID NANOPARTICLES,COATED NANOGELS,EFFICIENT,SP-B1-25,ALANINE,INHIBITION}},
language = {{eng}},
pages = {{16}},
title = {{Surfactant protein B-derived peptides as endosomal escape enhancers for pulmonary delivery of siRNA}},
url = {{http://doi.org/10.1016/j.jconrel.2025.02.067}},
volume = {{381}},
year = {{2025}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: